Details of the Drug
General Information of Drug (ID: DMPVI3A)
| Drug Name | 
                     Trisodium phosphate 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        TRISODIUM PHOSPHATE; 7601-54-9; Sodium orthophosphate; Tromete; Tribasic sodium phosphate; Phosphoric acid, trisodium salt; Oakite; Trisodium orthophosphate; Phosphoric acid trisodium salt; Trinatriumphosphat; Nutrifos STP; Tertiary sodium phosphate; Dri-Tri; Antisal 4; Sodium phosphate, anhydrous; Tribasic sodium orthophosphate; Caswell No. 898; Sodium tertiary phosphate; Sodium phosphate (VAN); UNII-SX01TZO3QZ; Emulsiphos 440/660; Trinatriumphosphat [German]; Trisodium phosphate anhydrous; Sodium phosphate (Na3PO4); Sodium ortho
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0  | 
                    Molecular Weight | 163.941 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
| Rotatable Bond Count | 0 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count | 4 | ||||||||||||||||||||||
| Chemical Identifiers | 
                        
  | 
                ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() Drug Off-Target (DOT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
                    
  | 
            ||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References



